No Data
No Data
Express News | Replimune Group Inc - Appoints Michael Goller to Board, Increases Board Size to Ten
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Replimune Group Is Maintained at Overweight by JP Morgan
J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $18
Replimune Price Target Raised to $18 From $16 at JPMorgan